Quanterix | Evaluate

Quanterix backs tau for Alzheimer’s diagnosis

Aduhelm approval amplifies amyloid assays

Biogen needs blood tests for amyloid beta to progress quickly – and several are in the pipeline.

April 19, 2021

A new market beckons for Alzheimer’s blood tests

If drugs acting on amyloid and tau can defy the sector’s history of failure, the testing landscape will change dramatically.

July 11, 2016

Medtech venture funding collapses